Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3

Watchlist Manager
Hapvida Participacoes e Investimentos SA Logo
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Watchlist
Price: 2.25 BRL -5.46% Market Closed
Market Cap: 17B BRL
Have any thoughts about
Hapvida Participacoes e Investimentos SA?
Write Note
Section:
 

Relative Value

The Relative Value of one HAPV3 stock under the Base Case scenario is 6.66 BRL. Compared to the current market price of 2.25 BRL, Hapvida Participacoes e Investimentos SA is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HAPV3 Relative Value
Base Case
6.66 BRL
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
73
vs Industry
70
Median 3Y
1.5
Median 5Y
3.8
Industry
2.3
Forward
0.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-39.6
Median 5Y
36.5
Industry
23.1
Forward
10.6
More Details
6.3
P/OCF
P/OCF
Price to OCF
6.3
vs History
98
vs Industry
32
Median 3Y
21.7
Median 5Y
42.6
Industry
14.2
More Details
31.4
P/FCFE
P/FCFE
Price to FCFE
31.4
vs History
26
vs Industry
5
Median 3Y
17.6
Median 5Y
18.1
Industry
20.1
More Details
0.3
P/B
P/B
Price to Book Value
0.3
vs History
93
vs Industry
74
Median 3Y
0.7
Median 5Y
1.1
Industry
2.2
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
73
vs Industry
68
Median 3Y
1.8
Median 5Y
4.2
Industry
2.4
Forward
0.8
More Details
5.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.5
vs History
73
vs Industry
54
Median 3Y
7.4
Median 5Y
13.5
Industry
5
More Details
7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7
vs History
98
vs Industry
35
Median 3Y
14
Median 5Y
26.2
Industry
12.7
Forward
5.8
More Details
15.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.8
vs History
98
vs Industry
20
Median 3Y
69
Median 5Y
46
Industry
17.1
Forward
14.5
More Details
8.5
EV/OCF
EV/OCF
Enterprise Value to OCF
8.5
vs History
98
vs Industry
29
Median 3Y
26.2
Median 5Y
44.7
Industry
14
More Details
10.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
10.7
vs History
74
vs Industry
26
Median 3Y
16.3
Median 5Y
36.3
Industry
18
More Details
0.3
EV/IC
EV/IC
Enterprise Value to IC
0.3
vs History
93
vs Industry
76
Median 3Y
0.6
Median 5Y
1
Industry
1.9
More Details

Multiples Across Competitors

HAPV3 Competitors Multiples
Hapvida Participacoes e Investimentos SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
17.1B BRL 1 -40 7 15.8
US
UnitedHealth Group Inc
NYSE:UNH
467.6B USD 1.2 32.7 13.9 15.7
US
Anthem Inc
LSE:0HG8
95.9B USD 0.6 14.9 10.6 12.3
US
Elevance Health Inc
NYSE:ELV
86B USD 0.5 13.4 9.7 11.2
US
Centene Corp
NYSE:CNC
30.7B USD 0.2 10 7.2 10.1
US
Humana Inc
NYSE:HUM
30.8B USD 0.3 22.7 8.5 10.9
US
Molina Healthcare Inc
NYSE:MOH
16.8B USD 0.4 14.7 5.5 6.1
US
Healthequity Inc
NASDAQ:HQY
8.3B USD 7.2 85.4 25 45.1
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 7.6 11.1 33
US
Clover Health Investments Corp
NASDAQ:CLOV
1.6B USD 1.1 -17.8 -18.5 -18.1
US
Progyny Inc
NASDAQ:PGNY
1.3B USD 1.1 22.4 15.3 16
P/E Multiple
Earnings Growth P/E to Growth
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Average P/E: 24.8
Negative Multiple: -40 		N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
32.7
40%
0.8
US
A
Anthem Inc
LSE:0HG8
14.9
60%
0.2
US
Elevance Health Inc
NYSE:ELV
13.4
60%
0.2
US
Centene Corp
NYSE:CNC
10
51%
0.2
US
Humana Inc
NYSE:HUM
22.7
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
14.7
56%
0.3
US
Healthequity Inc
NASDAQ:HQY
85.4
615%
0.1
US
M
Magellan Health Inc
F:MAH1
7.6
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.8 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
22.4
25%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Average EV/EBITDA: 11.4
7
72%
0.1
US
UnitedHealth Group Inc
NYSE:UNH
13.9
32%
0.4
US
A
Anthem Inc
LSE:0HG8
10.6
20%
0.5
US
Elevance Health Inc
NYSE:ELV
9.7
20%
0.5
US
Centene Corp
NYSE:CNC
7.2
6%
1.2
US
Humana Inc
NYSE:HUM
8.5
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
5.5
39%
0.1
US
Healthequity Inc
NASDAQ:HQY
25
136%
0.2
US
M
Magellan Health Inc
F:MAH1
11.1
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.5 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
15.3
262%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Average EV/EBIT: 17.6
15.8
191%
0.1
US
UnitedHealth Group Inc
NYSE:UNH
15.7
36%
0.4
US
A
Anthem Inc
LSE:0HG8
12.3
31%
0.4
US
Elevance Health Inc
NYSE:ELV
11.2
31%
0.4
US
Centene Corp
NYSE:CNC
10.1
20%
0.5
US
Humana Inc
NYSE:HUM
10.9
-38%
N/A
US
Molina Healthcare Inc
NYSE:MOH
6.1
41%
0.1
US
Healthequity Inc
NASDAQ:HQY
45.1
174%
0.3
US
M
Magellan Health Inc
F:MAH1
33
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -18.1 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
16
217%
0.1

See Also

Summary
HAPV3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
HAPV3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HAPV3 stock valuation using valuation multiples.
Wall Street Estimates
HAPV3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HAPV3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.